New Validated Rheumatoid Arthritis Study Services Now Available
January 2, 2013 - Rheumatoid arthritis (RA) is a long-term disease that leads to inflammation of the joints and surrounding tissues. It is an autoimmune disease occurring in every ethnic group, affecting nearly 1% of the world’s population, yet its cause remains unknown.
Charles River offers several rat and mouse models of RA, including collagen-induced arthritis (CIA) and collagen antibody-induced arthritis (CAIA), two of the most requested assays in the RA field of study.
Collagen-induced arthritis shares a number of immunologic and pathologic features with human RA. The model relies on the induction of an immune response to heterologous type-II collagen (C-II) and has been developed in rats and mice. While the clinical course of the disease in animals differs from that in humans, the synovial inflammation as analyzed by histology and immunohistochemistry is quite similar to that found in active RA in humans. In CIA, it is possible to study specific interactions between autoantigens, T-cells, antigen-presenting cells and anti−C-II antibodies. CAIA differs in that the disease is replicated using commercially acquired antibodies which are administered to the animal. This leads to a robust, even model of disease which requires a shorter study time than CIA, as the immune system does not need to be induced.
At Charles River, the course of the disease is monitored by measuring the total volume of the hind paws using a water plethysmometer and recording clinical scores for all 4 paws. Clinical scores are objectively assigned using the Holmdahl scoring system. This system assigns a score of 1 for every red or swollen digit, 5 for a swollen footpad and 5 for a swollen wrist or ankle. The maximum score achievable is 15 per limb, or 60 per animal. Overall disease burden is estimated by integrating the area under the hind limb swelling vs. time curve. Disease suppression is determined by calculating the relative area under the curve (AUC) for each treated animal relative to the mean AUC of the vehicle-treated control group, as a percentage.
Charles River also offers full histopathology options for limbs sampled from rodents at the end of the study.
For more information on our RA models, please contact us at 1.877.CRIVER.1 or firstname.lastname@example.org.
For more information, contact us at:
*indicates a required field.
The information you provided will be kept confidential.
We have established an in vivo screening platform to provide fast and cost-effective screening of compound effects on motor behavior and brain functionality for the study for central nervous system diseases.
We offer a package of well-established, state of the art in vitro mode of action assays that are suitable for early phase biocomparability studies, lot release and stability. These tests can accelerate the time it takes to get a new product ready for market submission.
May 28–Jun 01
The International Bone and Mineral Society (IBMS) and the Japanese Society for Bone and Mineral Research (JSBMR) are excited to sponsor the second joint scientific meeting by the two organizations.
May 27–May 29
Charles River and the René Remie Surgical Skills Centre (RRSSC) have joined their expertise and are pleased to offer a 3-day surgery training course. Held at the RRSSC in the Netherlands, this training is designed to be very practical and combines lectures with hands-on exercises, ensuring you receive the most comprehensive training experience. This course is recommended for simple procedures only (e.g., simple exeresis, simple catheterizations such as jugular vein or femoral vein, simple ALZET pump implantation, ECG radiotelemetry).
This position is responsible for serving as a as a study director (SD), project scientist (PS) and/or principal investigator (PI) in the direction and execution of assigned studies in compliance with GLP regulations as they apply to the conduct of nonclinical research; coordinating all phases of the study planning process with appropriate departments; generating high-quality project plans, protocols, amendments and reports appropriate for assigned studies; reviewing, interpreting, integrating and presenting data on assigned studies; and functioning as contact for the planning and execution of sponsor interaction related to assigned studies, including proposal management and study scheduling, conduct and reporting.
This position is responsible for managing international aspects of US Federal income tax compliance; assisting with international tax planning, including identification of planning opportunities, designing and implementing plans, and transfer pricing process; overseeing quarterly ETR forecast process; and participating in the tax provision process, including assessment of tax risks, documentation of key positions, and review of non-US tax provision submissions.
Charles River Laboratories, Inc.